{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:39:36Z","timestamp":1792669176552,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,2,13]],"date-time":"2015-02-13T00:00:00Z","timestamp":1423785600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s12035-015-9103-8","type":"journal-article","created":{"date-parts":[[2015,2,12]],"date-time":"2015-02-12T06:49:07Z","timestamp":1423723747000},"page":"1625-1636","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Validity of the MPTP-Treated Mouse as a Model for Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"53","author":[{"given":"Cornelius J. H. M.","family":"Klemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard J. M.","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Poelmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper E.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,13]]},"reference":[{"issue":"4587","key":"9103_CR1","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219(4587):979\u2013980","journal-title":"Science"},{"issue":"1","key":"9103_CR2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00441-004-0938-y","volume":"318","author":"A Schober","year":"2004","unstructured":"Schober A (2004) Classic toxin-induced animal models of Parkinson\u2019s disease: 6-OHDA and MPTP. Cell Tissue Res 318(1):215\u2013224","journal-title":"Cell Tissue Res"},{"issue":"5","key":"9103_CR3","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1046\/j.1471-4159.2001.00183.x","volume":"76","author":"S Przedborski","year":"2001","unstructured":"Przedborski S, Jackson-Lewis V, Naini AB, Jakowec M, Petzinger G, Miller R, Akram M (2001) The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety. J Neurochem 76(5):1265\u20131274","journal-title":"J Neurochem"},{"issue":"Database issue","key":"9103_CR4","doi-asserted-by":"publisher","first-page":"D191","DOI":"10.1093\/nar\/gkt1140","volume":"42","author":"C UniProt","year":"2014","unstructured":"UniProt C (2014) Activities at the universal protein resource (UniProt). Nucleic Acids Res 42(Database issue):D191\u2013198. doi:\n10.1093\/nar\/gkt1140","journal-title":"Nucleic Acids Res"},{"key":"9103_CR5","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1038\/tp.2013.48","volume":"3","author":"G Poelmans","year":"2013","unstructured":"Poelmans G, Franke B, Pauls DL, Glennon JC, Buitelaar JK (2013) AKAPs integrate genetic findings for autism spectrum disorders. Transl Psychiatr 3:e270. doi:\n10.1038\/tp.2013.48","journal-title":"Transl Psychiatr"},{"issue":"4","key":"9103_CR6","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1176\/appi.ajp.2010.10070948","volume":"168","author":"G Poelmans","year":"2011","unstructured":"Poelmans G, Pauls DL, Buitelaar JK, Franke B (2011) Integrated genome-wide association study findings: identification of a neurodevelopmental network for attention deficit hyperactivity disorder. Am J Psychiatry 168(4):365\u2013377. doi:\n10.1176\/appi.ajp.2010.10070948","journal-title":"Am J Psychiatry"},{"issue":"34","key":"9103_CR7","doi-asserted-by":"publisher","first-page":"7445","DOI":"10.1523\/jneurosci. 4204-03.2004","volume":"24","author":"RM Miller","year":"2004","unstructured":"Miller RM, Callahan LM, Casaceli C, Chen L, Kiser GL, Chui B, Kaysser-Kranich TM, Sendera TJ, et al (2004) Dysregulation of gene expression in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse substantia nigra. J Neurosci: Off J Soc Neurosci 24(34):7445\u20137454. doi:\n10.1523\/jneurosci. 4204-03.2004","journal-title":"J Neurosci: Off J Soc Neurosci"},{"issue":"1","key":"9103_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neuron.2009.12.023","volume":"65","author":"VM Nemani","year":"2010","unstructured":"Nemani VM, Lu W, Berge V, Nakamura K, Onoa B, Lee MK, Chaudhry FA, Nicoll RA, et al (2010) Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 65(1):66\u201379. doi:\n10.1016\/j.neuron.2009.12.023","journal-title":"Neuron"},{"issue":"6","key":"9103_CR9","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.neuron.2012.08.022","volume":"75","author":"S Matta","year":"2012","unstructured":"Matta S, Van Kolen K, da Cunha R, van den Bogaart G, Mandemakers W, Miskiewicz K, De Bock PJ, Morais VA, et al (2012) LRRK2 controls an EndoA phosphorylation cycle in synaptic endocytosis. Neuron 75(6):1008\u20131021. doi:\n10.1016\/j.neuron.2012.08.022","journal-title":"Neuron"},{"issue":"2","key":"9103_CR10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4161\/cib.3.2.10964","volume":"3","author":"S Bellani","year":"2010","unstructured":"Bellani S, Sousa VL, Ronzitti G, Valtorta F, Meldolesi J, Chieregatti E (2010) The regulation of synaptic function by alpha-synuclein. Commun Integr Biol 3(2):106\u2013109","journal-title":"Commun Integr Biol"},{"issue":"4","key":"9103_CR11","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/embj.201385902","volume":"33","author":"GL McLelland","year":"2014","unstructured":"McLelland GL, Soubannier V, Chen CX, McBride HM, Fon EA (2014) Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control. EMBO J 33(4):282\u2013295. doi:\n10.1002\/embj.201385902","journal-title":"EMBO J"},{"key":"9103_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","volume":"106\u2013107","author":"SR Subramaniam","year":"2013","unstructured":"Subramaniam SR, Chesselet MF (2013) Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease. Prog Neurobiol 106\u2013107:17\u201332. doi:\n10.1016\/j.pneurobio.2013.04.004","journal-title":"Prog Neurobiol"},{"issue":"3","key":"9103_CR13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.nbd.2009.05.023","volume":"35","author":"Y Chu","year":"2009","unstructured":"Chu Y, Dodiya H, Aebischer P, Olanow CW, Kordower JH (2009) Alterations in lysosomal and proteasomal markers in Parkinson\u2019s disease: relationship to alpha-synuclein inclusions. Neurobiol Dis 35(3):385\u2013398. doi:\n10.1016\/j.nbd.2009.05.023","journal-title":"Neurobiol Dis"},{"issue":"36","key":"9103_CR14","doi-asserted-by":"publisher","first-page":"14729","DOI":"10.1073\/pnas.1216844110","volume":"110","author":"A Berthier","year":"2013","unstructured":"Berthier A, Jimenez-Sainz J, Pulido R (2013) PINK1 regulates histone H3 trimethylation and gene expression by interaction with the polycomb protein EED\/WAIT1. Proc Natl Acad Sci U S A 110(36):14729\u201314734. doi:\n10.1073\/pnas.1216844110","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"9103_CR15","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3727\/096368912x655154","volume":"22","author":"RH Fu","year":"2013","unstructured":"Fu RH, Liu SP, Huang SJ, Chen HJ, Chen PR, Lin YH, Ho YC, Chang WL, et al (2013) Aberrant alternative splicing events in Parkinson\u2019s disease. Cell Transplant 22(4):653\u2013661. doi:\n10.3727\/096368912x655154","journal-title":"Cell Transplant"},{"issue":"12","key":"9103_CR16","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/0028-3908(89)90020-8","volume":"28","author":"U Bonuccelli","year":"1989","unstructured":"Bonuccelli U, Fariello RG (1989) Evidence for an epileptogenic action of 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine. Neuropharmacology 28(12):1419\u20131422","journal-title":"Neuropharmacology"},{"issue":"1","key":"9103_CR17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0304-3940(91)90813-9","volume":"124","author":"U Bonuccelli","year":"1991","unstructured":"Bonuccelli U, Garant D, Fariello R (1991) The acute convulsant effect of MPTP is dependent on intracerebral MPP+. Neurosci Lett 124(1):22\u201326","journal-title":"Neurosci Lett"},{"issue":"12","key":"9103_CR18","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1111\/j.0013-9580.2004.17504.x","volume":"45","author":"A Gaitatzis","year":"2004","unstructured":"Gaitatzis A, Carroll K, Majeed A, Sander JW (2004) The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia 45(12):1613\u20131622. doi:\n10.1111\/j.0013-9580.2004.17504.x","journal-title":"Epilepsia"},{"issue":"2","key":"9103_CR19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0006-8993(89)91370-X","volume":"504","author":"PC Ness Van","year":"1989","unstructured":"Van Ness PC, Olsen RW, Verity MA (1989) MPTP is proconvulsant acutely but has no long-term effect in rodent models of seizure and epilepsy. Brain Res 504(2):289\u2013292","journal-title":"Brain Res"},{"issue":"41","key":"9103_CR20","doi-asserted-by":"publisher","first-page":"14389","DOI":"10.1523\/jneurosci. 3408-12.2012","volume":"32","author":"TL Beaumont","year":"2012","unstructured":"Beaumont TL, Yao B, Shah A, Kapatos G, Loeb JA (2012) Layer-specific CREB target gene induction in human neocortical epilepsy. J Neurosci: Off J Soc Neurosci 32(41):14389\u201314401. doi:\n10.1523\/jneurosci. 3408-12.2012","journal-title":"J Neurosci: Off J Soc Neurosci"},{"issue":"5","key":"9103_CR21","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.etp.2012.1009.1001","volume":"65","author":"S Pain","year":"2013","unstructured":"Pain S, Gochard A, Bodard S, Gulhan Z, Prunier-Aesch C, Chalon S, Luchtman DW, Shao D, et al (2013) Toxicity of MPTP on neurotransmission in three mouse models of Parkinson\u2019s disease. Exp Toxicol Pathol 65(5):689\u2013694. doi:\n10.1016\/j.etp.2012.1009.1001","journal-title":"Exp Toxicol Pathol"},{"issue":"1\u20132","key":"9103_CR22","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.physbeh.2009.1004.1021","volume":"98","author":"DW Luchtman","year":"2009","unstructured":"Luchtman DW, Shao D, Song C (2009) Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse. Physiol Behav 98(1\u20132):130\u2013138. doi:\n10.1016\/j.physbeh.2009.1004.1021","journal-title":"Physiol Behav"},{"issue":"5","key":"9103_CR23","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/j.1471-4159.2012.07837.x","volume":"122","author":"S Schumm","year":"2012","unstructured":"Schumm S, Sebban C, Cohen-Salmon C, Callebert J, Launay JM, Golmard JL, Boussicault L, Petropoulos I, et al (2012) Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J Neurochem 122(5):1032\u20131046","journal-title":"J Neurochem"},{"issue":"11","key":"9103_CR24","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s007020100004","volume":"108","author":"N Schmidt","year":"2001","unstructured":"Schmidt N, Ferger B (2001) Neurochemical findings in the MPTP model of Parkinson\u2019s disease. J Neural Transm 108(11):1263\u20131282","journal-title":"J Neural Transm"},{"issue":"4","key":"9103_CR25","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1471-4159.1986.tb00722.x","volume":"47","author":"RA Mayer","year":"1986","unstructured":"Mayer RA, Kindt MV, Heikkila RE (1986) Prevention of the nigrostriatal toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by inhibitors of 3,4-dihydroxyphenylethylamine transport. J Neurochem 47(4):1073\u20131079","journal-title":"J Neurochem"},{"issue":"5","key":"9103_CR26","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1046\/j.1471-4159.1998.70051973.x","volume":"70","author":"RR Gainetdinov","year":"1998","unstructured":"Gainetdinov RR, Fumagalli F, Wang YM, Jones SR, Levey AI, Miller GW, Caron MG (1998) Increased MPTP neurotoxicity in vesicular monoamine transporter 2 heterozygote knockout mice. J Neurochem 70(5):1973\u20131978","journal-title":"J Neurochem"},{"issue":"2","key":"9103_CR27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0304-3940(90)90614-F","volume":"118","author":"KJ Campbell","year":"1990","unstructured":"Campbell KJ, Takada M, Hattori T (1990) Evidence for retrograde axonal transport of MPP+ in the rat. Neurosci Lett 118(2):151\u2013154","journal-title":"Neurosci Lett"},{"key":"9103_CR28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1749-6632.2003.tb07476.x","volume":"991","author":"S Przedborski","year":"2003","unstructured":"Przedborski S, Vila M (2003) The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson\u2019s disease. Ann N Y Acad Sci 991:189\u2013198","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"9103_CR29","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0969-9961(03)00011-1","volume":"13","author":"W Meissner","year":"2003","unstructured":"Meissner W, Dovero S, Bioulac B, Gross CE, Bezard E (2003) Compensatory regulation of striatal neuropeptide gene expression occurs before changes in metabolic activity of basal ganglia nuclei. Neurobiol Dis 13(1):46\u201354","journal-title":"Neurobiol Dis"},{"issue":"1","key":"9103_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/ajmg.b.30195","volume":"137B","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, James M, Middleton FA, Davis RL (2005) Transcriptional analysis of multiple brain regions in Parkinson\u2019s disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms. Am J Med Genet Part B, Neuropsychiatr Genet: Off Publ Int Soc Psychiatr Genet 137B(1):5\u201316. doi:\n10.1002\/ajmg.b.30195","journal-title":"Am J Med Genet Part B, Neuropsychiatr Genet: Off Publ Int Soc Psychiatr Genet"},{"issue":"1","key":"9103_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10048-005-0020-2","volume":"7","author":"LB Moran","year":"2006","unstructured":"Moran LB, Duke DC, Deprez M, Dexter DT, Pearce RK, Graeber MB (2006) Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson\u2019s disease. Neurogenetics 7(1):1\u201311. doi:\n10.1007\/s10048-005-0020-2","journal-title":"Neurogenetics"},{"issue":"3","key":"9103_CR32","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.nbd.2007.02.009","volume":"26","author":"I Cantuti-Castelvetri","year":"2007","unstructured":"Cantuti-Castelvetri I, Keller-McGandy C, Bouzou B, Asteris G, Clark TW, Frosch MP, Standaert DG (2007) Effects of gender on nigral gene expression and parkinson disease. Neurobiol Dis 26(3):606\u2013614. doi:\n10.1016\/j.nbd.2007.02.009","journal-title":"Neurobiol Dis"},{"issue":"6","key":"9103_CR33","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1371\/journal.pgen.0030098","volume":"3","author":"TG Lesnick","year":"2007","unstructured":"Lesnick TG, Papapetropoulos S, Mash DC, Ffrench-Mullen J, Shehadeh L, de Andrade M, Henley JR, Rocca WA, et al (2007) A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. PLoS Genet 3(6):e98. doi:\n10.1371\/journal.pgen.0030098","journal-title":"PLoS Genet"},{"issue":"1","key":"9103_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1750-3639.2008.00171.x","volume":"19","author":"K Bossers","year":"2009","unstructured":"Bossers K, Meerhoff G, Balesar R, van Dongen JW, Kruse CG, Swaab DF, Verhaagen J (2009) Analysis of gene expression in Parkinson\u2019s disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death. Brain Pathol (Zurich, Switzerland) 19(1):91\u2013107. doi:\n10.1111\/j.1750-3639.2008.00171.x","journal-title":"Brain Pathol (Zurich, Switzerland)"},{"issue":"52","key":"9103_CR35","doi-asserted-by":"publisher","first-page":"52ra73","DOI":"10.1126\/scitranslmed.3001059","volume":"2","author":"B Zheng","year":"2010","unstructured":"Zheng B, Liao Z, Locascio JJ, Lesniak KA, Roderick SS, Watt ML, Eklund AC, Zhang-James Y, et al (2010) PGC-1alpha, a potential therapeutic target for early intervention in Parkinson\u2019s disease. Sci Transl Med 2(52):52ra73. doi:\n10.1126\/scitranslmed.3001059","journal-title":"Sci Transl Med"},{"issue":"1","key":"9103_CR36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00401-011-0828-9","volume":"122","author":"M Elstner","year":"2011","unstructured":"Elstner M, Morris CM, Heim K, Bender A, Mehta D, Jaros E, Klopstock T, Meitinger T, et al (2011) Expression analysis of dopaminergic neurons in Parkinson\u2019s disease and aging links transcriptional dysregulation of energy metabolism to cell death. Acta Neuropathol 122(1):75\u201386. doi:\n10.1007\/s00401-011-0828-9","journal-title":"Acta Neuropathol"},{"issue":"12","key":"9103_CR37","doi-asserted-by":"publisher","first-page":"e52319","DOI":"10.1371\/journal.pone.0052319","volume":"7","author":"H Diao","year":"2012","unstructured":"Diao H, Li X, Hu S, Liu Y (2012) Gene expression profiling combined with bioinformatics analysis identify biomarkers for Parkinson disease. PLoS ONE 7(12):e52319. doi:\n10.1371\/journal.pone.0052319","journal-title":"PLoS ONE"},{"issue":"2","key":"9103_CR38","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.expneurol.2006.01.008","volume":"199","author":"IR Vogt","year":"2006","unstructured":"Vogt IR, Lees AJ, Evert BO, Klockgether T, Bonin M, Wullner U (2006) Transcriptional changes in multiple system atrophy and Parkinson\u2019s disease putamen. Exp Neurol 199(2):465\u2013478. doi:\n10.1016\/j.expneurol.2006.01.008","journal-title":"Exp Neurol"},{"issue":"1","key":"9103_CR39","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.nbd.2011.08.033","volume":"45","author":"T Botta-Orfila","year":"2012","unstructured":"Botta-Orfila T, Tolosa E, Gelpi E, Sanchez-Pla A, Marti MJ, Valldeoriola F, Fernandez M, Carmona F, et al (2012) Microarray expression analysis in idiopathic and LRRK2-associated Parkinson\u2019s disease. Neurobiol Dis 45(1):462\u2013468. doi:\n10.1016\/j.nbd.2011.08.033","journal-title":"Neurobiol Dis"},{"issue":"4","key":"9103_CR40","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.neuroscience.2008.06.064","volume":"155","author":"R Pattarini","year":"2008","unstructured":"Pattarini R, Rong Y, Qu C, Morgan JI (2008) Distinct mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine resistance revealed by transcriptome mapping in mouse striatum. Neuroscience 155(4):1174\u20131194. doi:\n10.1016\/j.neuroscience.2008.06.064","journal-title":"Neuroscience"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-015-9103-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9103-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9103-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9103-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T23:16:20Z","timestamp":1553642180000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-015-9103-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,13]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["9103"],"URL":"https:\/\/doi.org\/10.1007\/s12035-015-9103-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,13]]}}}